Xtant Medical Holdings (XTNT) Shares Outstanding (Diluted Average) (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Shares Outstanding (Diluted Average) data on file, last reported at $150.0 million in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $150.0 million, up 12.25% year-over-year; the trailing twelve-month figure through Dec 2025 was $150.0 million (up 12.25% YoY), and the FY2025 annual result was $150.0 million, up 12.25% from the prior year.
• Shares Outstanding (Diluted Average) was little changed at $150.0 million in Q4 2025 per XTNT's latest filing, from $149.9 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $150.0 million in Q4 2025 and troughed at $81.2 million in Q1 2021.
• A 5-year average of $114.3 million and a median of $116.4 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Diluted Average) jumped 555.7% in 2021, then advanced 0.63% in 2022.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $85.5 million in 2021, then gained by 10.1% to $94.1 million in 2022, then soared by 34.76% to $126.8 million in 2023, then grew by 5.42% to $133.7 million in 2024, then rose by 12.25% to $150.0 million in 2025.
• Business Quant data shows XTNT's Shares Outstanding (Diluted Average) at $150.0 million in Q4 2025, $149.9 million in Q3 2025, and $148.6 million in Q2 2025.